THYTREG

Serial Number 79375552
Registration 7616715
700

Registration Progress

Application Filed
Jun 2, 2023
Under Examination
Approved for Publication
Oct 22, 2024
Published for Opposition
Oct 22, 2024
Registered
Dec 24, 2024

Basic Information

Serial Number
79375552
Registration Number
7616715
Filing Date
June 2, 2023
Registration Date
December 24, 2024
Published for Opposition
October 22, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 24, 2024
Registration
Registered
Classes
005 042 044

Rights Holder

Thytech, S.L.

99
Address
Calle Islas Bahamas, 27
E-28035 Madrid
ES

Ownership History

Thytech, S.L.

Original Applicant
99
ES

Thytech, S.L.

Owner at Publication
99
ES

Thytech, S.L.

Original Registrant
99
ES

Legal Representation

Attorney
Ashford Tucker

USPTO Deadlines

Next Deadline
1994 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-24)
Due Date
December 24, 2030
Grace Period Ends
June 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description
Jul 5, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 1, 2025 NURC C NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Jun 12, 2025 COC. O CORRECTION UNDER SECTION 7 - PROCESSED
Jun 12, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 12, 2025 FIMP P FINAL DISPOSITION PROCESSED
Jun 12, 2025 LIME I LIMITATION FROM THE IB EXAMINED AND ENTERED
Jun 12, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Mar 24, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 17, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 1, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 1, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 24, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 24, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 13, 2024 LIMG M LIMITATION OF GOODS RECEIVED FROM IB
Oct 22, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2024 PUBO A PUBLISHED FOR OPPOSITION
Oct 2, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 16, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 13, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 12, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 12, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 12, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 12, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 12, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 8, 2024 RFNT P REFUSAL PROCESSED BY IB
Mar 16, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 16, 2024 RFRR P REFUSAL PROCESSED BY MPU
Mar 16, 2024 RFRR P REFUSAL PROCESSED BY MPU
Feb 24, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 23, 2024 CNRT R NON-FINAL ACTION WRITTEN
Feb 23, 2024 DOCK D ASSIGNED TO EXAMINER
Aug 8, 2023 MAFR O APPLICATION FILING RECEIPT MAILED
Aug 4, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 3, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of immune system related and inflammatory diseases and disorders; immune-system [ regulator agents ] * therapeutic cellular preparations * being regulatory T cells for medical purposes
Class 042
Technological and scientific research services in cell population separation; Technological and scientific research services in cell population separation aimed at controlling and modulating the immune system; information services and data services in the nature of providing medical and scientific research information and compiling data for research purposes in the field of medical science and medical consultancy, both regarding medical research and development
Class 044
Medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes related to the treatment of patients; medical immunological analyses relating to the treatment of patients; cell therapy services

Additional Information

Other
In the statement, Class 5 has been corrected per the Public note date 06/10/2025.

Classification

International Classes
005 042 044